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Maitohappobakteereilla on pitkä käyttöhistoria elintarvikkeiden valmistuksessa johtuen niiden 
hyödyllisistä metabolisista ominaisuuksista sekä terveyttä edistävistä vaikutuksista. Pitkän 
käyttöhistoriansa vuoksi maitohappobakteereita pidetään turvallisina ja suurimmalla osalla niistä 
onkin FDA:n (U.S Food and Drug Administration) myöntämä GRAS (Generally Recognized As Safe) 
-status sekä EFSA:n (European Food Safety Authority) myöntämä QPS (Qualified Presumption of 
Safety) -status. Antimikrobiresistenssi on maailmanlaajuinen ongelma ja yhä useampi infektiosairaus 
on kasvavan resistenssin vuoksi vaikeampi hoitaa. Antimikrobiresistenssi on luonnollisesti suurin 
ongelma tautia aiheuttavissa mikrobeissa, mutta resistenssien lisääntyessä olisi hyvä ottaa huomioon 
myös ihmiselle hyödylliset mikrobit ja niiden mahdollinen kyky levittää geenejä ympäristöönsä ja 
myös patogeenisiin mikrobeihin. Fermentoidut elintarvikkeet luovat suotuisan ympäristön 
antimikrobisten geenien leviämiselle mm. sen vuoksi, että niissä voi olla korkeita määriä eläviä 
mikrobeja.  
 
Tämän työn tarkoituksena oli selvittää Lactobacillus rhamnosus-, Lactobacillus plantarum-, 
Leuconostoc sp.- ja Weissella sp. -kantojen antibioottiherkkyyksiä ja etsiä kannoista mahdollisia 
antibioottiresistenssigeenejä. Kantojen fenotyyppistä antibioottiherkkyyttä tutkittiin E-testi -
menetelmän avulla. Antibioottiherkkyyksiä testattiin kahdeksalle eri antibiootille, jotka olivat 
ampisilliini, kloramfenikoli, klindamysiini, erytromysiini, gentamisiini, kanamysiini, streptomysiini ja 
tetrasykliini. Kannoista etsittiin antibioottiresistenssigeenejä blaZ, mecA, cat, lnuA, tetK ja tetM 
spesifisillä PCR-menetelmillä. Antibioottiherkkyyksien selvittämisen lisäksi Weissella sp. -kannoille 
pyrittiin määrittämään raja-arvot (cut-off), joita sillä ei EFSA:n määrittämänä entuudestaan ole. 
 
Fenotyyppisissä antibioottiherkkyysmäärityksissä suurimman osan testatuista kannoista huomattiin 
olevan resistenttejä kanamysiinille. Leuconostoc sp.- ja L. rhamnosus -kannoista huomattava osa 
osoittautui resistenteiksi myös kloramfenikolille. Tutkimuksessa yhden L. rhamnosus -kannan 
todettiin olevan resistentti sekä kloramfenikolille että klindamysiinille. Tämän lisäksi 48 %:lla 
testatuista Leuconostoc sp. -kannoista oli EFSA:n määrittämää raja-arvoa suurempi MIC-arvo 
streptomysiinille. Vaikka fenotyyppisissä määrityksissä havaittiinkin resistenssiä joillekin 
antibiooteille, etsittyjä resistenssigeenejä ei kuitenkaan löydetty yhdeltäkään testatuista 
maitohappobakteerikannoista. Tämä selittynee osittain sillä, että tutkimuksessa etsittiin vain pientä 
osaa tunnetuista antibioottiresistenssigeeneistä. EFSA:n asettamat raja-arvot ovat myös varsin tiukat, 
jolloin arvojen ylityksiä havaitaan helpommin. Tutkimuksessa saadut tulokset toivat paljon lisätietoa 
L. rhamnosus-, L. plantarum-, Leuconostoc sp.- ja Weissella sp. -kantojen antibioottiherkkyydestä ja 
niiden käyttöturvallisuudesta. Lisäksi tutkimuksessa pystyttiin määrittämään Weissella -kannoilta 
vielä puuttuvat cut-off-arvot. 
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Lactic acid bacteria have a long history of use in food industry due to their favorable metabolic 
properties and health benefits for human health. Therefore, they are generally recognized as safe 
(GRAS) by FDA (U.S Food and Drug Administration) and have QPS (Qualified Presumption of 
Safety) status granted by EFSA (European Food Safety Authority). Nowadays, antimicrobial resistance 
(AMR) is a serious global risk and due to the increasing AMRs, more and more microbial infections 
have become more difficult to treat with antibiotics. AMR has mainly been of concern in relation to 
pathogenic microbes. However, since fermented foods are favorable environments for AMR gene 
transfer it should also be considered in the context of beneficial bacteria and their potential to spread 
AMR genes into pathogenic microbes. 
 
The aim of this study was to determine antibiotic susceptibilities of Lactobacillus plantarum, 
Lactobacillus rhamnosus, Leuconostoc sp. and Weissella sp. strains by E-test method and to detect 
selected specific antibiotic resistance genes by PCR. In addition, the goal was to define new cut-off 
values for Weissella strains since, so far, these have not been defined by EFSA. Antibiotic 
susceptibilities were determined against eight antibiotics: ampicillin, chloramphenicol, clindamycin, 
erythromycin, gentamicin, kanamycin, streptomycin and tetracycline. The detected AMR genes were 
blaZ, mecA, cat, lnuA, tetK and tetM. 
 
Most of the determined strains were observed to exhibit a notable resistance to kanamycin. Several 
Leuconostoc sp. and L. rhamnosus strains showed also resistance to chloramphenicol. Interestingly, 
one L. rhamnosus strain was observed to exhibit multiresistance to chloramphenicol and clindamycin. 
Moreover, 48% Leuconostoc strains had higher MIC value for streptomycin than the cut-off value 
defined by EFSA. Any of the selected AMR genes were not detected even though a notable resistance 
during the phenotypic testing was observed. However, this might be explained by the small amount of 
detected AMR genes. The results obtained in the present study provided more information about the 
antibiotic susceptibility and the safety of L. plantarum, L. rhamnosus, Leuconostoc sp. and Weissella 
sp. strains. Moreover, new cut-off values were proposed for Weissella sp. strains. 
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1 Introduction 
 
Antimicrobials including antibiotics, antifungals, antivirals and antiprotozoals, are substances 
that may kill or inhibit microbial growth [1]. Generally, antimicrobials are used for the 
treatment of microbial infections in humans and animals [1]. In agriculture, antimicrobials 
have also been used for the prevention of diseases in healthy animals but also for treatment 
and prevention of plant diseases [2, 3]. Moreover, some antimicrobials used against plant 
infections, such as tetracyclines and streptomycin, are also used to treat humans and animals 
[3]. In certain countries, including US, antimicrobials are also used as growth promoters 
although this has been banned in the EU since 2006 [2].   
Antimicrobial resistance (AMR) is a serious global risk for human health [4]. 
Increased occurrence of resistant microbes is largely due to the misuse of antimicrobials in 
health care and agriculture [1, 3]. Fast action against AMR is essential since otherwise the 
treatment of increasing number of microbial infections will be much more challenging [1]. 
European Commission has accepted the EU one health action plan against antimicrobial 
resistance which forms the basis for wider action against AMR. The main aims of the action 
plan are to encourage the research and development of new antimicrobials and to provide 
novel knowledge and solutions for the treatment of microbial infections [1]. The goal is also 
to be a pioneer in preventing the spread of AMR and to form a worldwide plan against AMR 
[1]. 
Antimicrobial resistance can be either intrinsic or acquired. Intrinsic resistance 
occurs inherently in the strains of certain species and it is generally assumed to be caused by 
either active efflux pumps or reduced permeability of the bacterial outer membrane [5].  In 
the case of intrinsic resistance the risk of transferring AMR genes to other microbes is not 
considered to be as high as in acquired resistance [6]. Microbes that are inherently susceptible 
to a certain antibiotic can acquire resistance via a genetic mutation or gene transfer from one 
microbe to another [7, 8]. Gene transfer is not depended on species or genus lineages and 
therefore acquired resistance genes do not occur in all strains of a certain species [7, 9]. This 
is the hallmark of acquired resistance. Gene transfer over the species and genus borders is 
also known as horizontal gene transfer where the genes are typically located on mobile 
genetic elements such as plasmids and transposons [6, 8, 9]. Gene cassettes and integrons 
play an essential role in spreading of antimicrobial resistance genes due to the integrons 
ability to capture and express multiple gene cassettes with antimicrobial resistance genes  [10, 
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11]. The principal mechanisms of microbial genetic material transfer are conjugation, 
transduction and transformation [8]. In transformation the lysis of donor cells releases free 
genetic material which can be incorporated into the resipient cell genome [12]. In 
transduction the genes are transmitted from one bacterial cell to another by bacteriophages 
while in conjugation the genetic material, mainly plasmids, is transferred from donor cell to 
resipient cell by cell-to-cell contact  [12].  
Acquired AMR resistance is a serious issue in pathogenic bacteria, but it should 
also be considered in the context of beneficial bacteria (starters, probiotics, protective 
cultures). Bacteria that are used in food/feed industry and agriculture (for example lactic acid 
bacteria, bifidobacteria, bacilli, enterococci) can also carry and spread acquired AMR genes 
and therefore determining their potential to carry acquired AMR genes is important [13]. The 
use of strains with acquired AMR genes should be avoided to prevent the further spread of 
the genes. Fermented foods are favorable environments for gene transfer due to the presence 
of large number of living bacterial cells and the presence of multiple stress factors such as 
low pH and antimicrobial compounds, such as lactic acid and other organic acids, antifungal 
peptides and bacteriocins [14]. 
Lactic acid bacteria (LAB) are gram-positive, nonsporulating, catalase- and 
oxidase-negative typically cocci- or rod-shaped bacteria that are generally defined by their 
ability to produce lactic acid as a major or sole fermentation end product [12]. The majority 
of lactic acid bacteria belong to the phylum Firmicutes [12]. This diverse group of bacteria 
consists of various phylogenetic branches including for instance the genera of Lactobacillus, 
Lactococcus, Leuconostoc and Weissella [15, 16].  
Lactic acid bacteria have been widely used in the food industry for several 
decades and they are generally recognized as safe (GRAS) by the FDA (U.S Food and Drug 
Administration) [13]. In addition, many LAB species have QPS (Qualified Presumption of 
Safety) status defined by EFSA (European Food Safety Authority) [17]. QPS status is granted 
for microbes with sufficient evidence of their safe consumption and therefore microbes with 
QPS status do not need to go through the full safety assessment [17]. Lactic acid bacteria are 
important dairy starter cultures and play an essential role in the production of fermented food 
products [9]. In addition, these bacteria are often used as probiotics. World Health 
Organization (WHO) has defined probiotics as “Live microorganisms which when 
administered in adequate amounts confer a health benefit on the host” [18].  The interest in 
producing foods with health benefits is constantly increasing and therefore LAB, such as 
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Lactobacillus strains, are added in to the functional food products [12]. The reported health 
benefits of probiotics are usually connected to the enhancement of intestinal health that 
includes balancing of intestinal microbiota. A healthy intestinal microbiota have been 
described to be beneficial to the immune system [19]. In addition, the studies has reported 
that the consumption of probiotics may have beneficial effects for instance in the prevention 
of antibiotic associated diarrhea and allergic diseases [20, 21].  
Lactic acid bacteria grow under anaerobic or micro-aerophilic conditions [22]. 
Most LAB species are aerotolerant meaning that they are not very sensitive to oxygen (O2) 
[23]. Lactic acid bacteria generally obtain energy only via fermentation of sugars and 
therefore they usually grow in sugar-rich environments [12]. Lactic acid bacteria can utilize 
carbohydrates by either homolactic or heterolactic fermentation [22]. In homolactic 
fermentation, hexose is converted to lactic acid and hydrogen (H2)
 [12]. This metabolic 
pathway is typical for Lactococcus and Pediococcus species and also for some Lactobacillus 
species [24, 25]. Heterolactic fermentation produces ethanol or/and acetic acid, carbon 
dioxide (CO2) and hydrogen (H2) besides lactic acid from a single hexose molecule [12, 26]. 
This type of fermentation is typical for instance in Leuconostoc species [27].  
Lactobacillus species are Gram-positive, non-spore forming and generally rod-
shaped bacteria that utilize carbohydrates by either homolactic or heterolactic fermentation 
[26]. They are catalase-negative and usually non-motile [26]. Lactobacillus species have 
many nutritional requirements due to the need of additional energy and carbon sources, such 
as amino acids and vitamins, besides carbohydrates [26, 28]. Usually, the optimal growth 
temperature of Lactobacillus species varies between 30 and 40 °C and the optimal pH range 
is 5.5-6.2 [28, 29]. Lactobacillus species are aerotolerant but they typically grow in anaerobic 
environments [29]. The most common growing environments are dairy, grain and meat 
products as well as beer, wine and fruit juices [28]. In addition, some Lactobacillus species 
also belong to the resident microbiota of human and animal mouth and intestinal track [28]. 
Lactobacillus species have a long history of use in the food industry due to their efficacy in 
fermenting foods and potential to improve their structure, sensory properties, and storage 
stability. However, contaminating lactobacilli can sometimes turn into spoilage organisms 
especially if their metabolisms causes undesired changes in the sensory properties of the 
foods [28, 29]. 
Leuconostoc species are phylogenetically close to the genus Lactobacillus [30]. 
They are Gram-positive, non-motile and coccoid-shaped bacteria, which typically grow at the 
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temperatures between 20 and 30 °C in the pH range 6 to 7 [31]. Leuconostoc species grow in 
various environments for instance in dairy products, meat, and fermented vegetable products. 
[30, 31]. Besides their importance in the fermentation process, especially as acidity and flavor 
producers, Leuconostoc species may also cause food spoilage [30, 31]. 
Phylogenetically close to Leuconostoc genus is the genus Weissella, which also 
belongs to the family of Leuconostocaceae [32]. Weissella species are Gram-positive, 
catalase-negative, generally non-motile and non-spore-forming bacteria, which are shaped as 
rods or ovoid. Typically, their growth occurs between 15-45 °C depending on the strain [33]. 
Various species of Weissella grow in diverse habitats including environment (soil, 
sediments), plants, and fermented, mainly milk and plant based, foods. They can also be 
detected in e.g. saliva and faces of humans and animals [32, 34]. Weissella species are 
facultatively anaerobic and utilize glucose by heterolactic fermentation [32].  One of the main 
advantages in the metabolism of Weissella species is the production of exopolysaccharides, 
such as dextran, which have variable applications in food industry and especially in the 
fermentation of cereal-based products [34].  
EFSA has a guidance for the safety assessment (including the presence of 
acquired AMR genes) of microbes used as feed additives or as production organisms in the 
EU [35]. According to this guidance the safety of the strain may be ensured by proper 
characterization including the strain identification, determination of antimicrobial 
susceptibilities and antimicrobial production and also the information about toxigenicity and 
pathogenicity, based on species specific requirements [35]. It can be assumed that in the 
future this guidance will most likely be applied also to microbes used in foods in the EU. 
EFSA has defined cut-off values to certain antimicrobials with the purpose of helping to 
identify the strains carrying acquired AMR genes [35]. The phenotypic antimicrobial 
susceptibility is determined by defining the MIC (Minimum Inhibitory Concentration) values 
for the antimicrobials listed in the guidance. The strains having higher MIC values than the 
defined cut-off values may carry acquired AMR genes requiring more investigation. The 
antimicrobials for which EFSA has defined cut-off values for lactic acid bacteria include 
ampicillin, chloramphenicol, clindamycin, erythromycin, gentamicin, kanamycin, 
streptomycin, tetracycline and vancomycin. The sites of inhibition and modes of action of 
these antibiotics are displayed in Table 1. In addition, the cut-off values defined by EFSA for 
Lactobacillus plantarum, Lactobacillus rhamnosus and Leuconostoc spp. are presented in 
Table 2. For Weissella there are currently no EFSA’s cut-off values.  
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Table 1 Antibiotic groups relevant in present study and the their modes of action [13, 36] 
 
Site of 
action 
Group Antibiotic Mode of action 
Cell wall 
synthesis 
β-lactams Ampicillin Interaction with 
penicillin 
binding proteins 
(PBPs)  
Disruption of peptidoglycan 
layer and cell lysis 
Glycopeptides Vancomycin Interaction with 
D-alanyl-D-
alanine termini 
of peptidoglycan 
chain 
Prevent the binding of D-alanyl 
subunit with the PBP 
Protein 
synthesis 
 
Aminoglycosides Gentamicin 30S ribosomal 
subunit 
Misreadings and premature 
termination of mRNA translation Kanamycin 
Streptomycin 
Chloramphenicols Chloramphenicol 50S ribosomal 
subunit 
Prevent binding of t-RNA to the 
A site 
Lincosamides Clindamycin 50S ribosomal 
subunit 
Affects the peptidyl transferase 
reactions resulting premature 
detachment of incomplete 
peptide chains 
Macrolides Erythromycin 50S ribosomal 
subunit 
Affects the peptidyl transferase 
reactions resulting premature 
detachment of incomplete 
peptide chains 
Tetracyclines Tetracycline 30S ribosomal 
subunit 
Prevent binding of t-RNA to the 
A site 
 
Table 2. Microbiological cut-off values (µg mL-1) for Lactobacillus plantarum, Lactobacillus 
rhamnosus, and Leuconostoc spp. defined by EFSA (EFSA 2018). n.r: not required 
 
LAB groups 
Antibiotic (µg mL-1) 
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Lactobacillus 
plantarum 2 8 4 1 16 64 n.r. 32 
Lactobacillus 
rhamnosus 4 4 4 1 16 64 32 8 
Leuconostoc 
spp. 2 4 1 1 16 16 64 8 
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The aim of this study was to characterize and evaluate the safety of 
Lactobacillus, Leuconostoc and Weissella strains by determining the MIC values of selected 
strains against eight antibiotics and by studying the presence of certain specific antibiotic 
resistance genes in the strains. In addition, the goal was also to try to set new cut-off values 
for Weissella and find out if the determined MIC values relate to the presence of antibiotic 
resistance genes in the strains.  
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2 Materials and methods 
 
2.1 Bacterial strains and growth conditions 
 
In total, 105 lactic acid bacterial strains representing the genera Lactobacillus (53), 
Leuconostoc (29) and Weissella (22) were selected for antibiotic susceptibility testing from 
the culture collection of VTT. The selected strains and their origins are shown in Table 3. The 
strains were cultivated on MRS medium (CM0361, Oxoid, UK) and incubated anaerobically 
(10 % (v/v) H2, 5 % (v/v) CO2 and 85 % (v/v) N2) or in microaerophilic conditions (6 % (v/v) 
O2) for 24 h at 25-37 °C depending on the strain. The favorable growing atmospheres were 
obtained by using Anoxomat (Mart Microbiology B.V., The Netherlands).  
The correct identification of the strains was confirmed by MALDI Biotyper 4.1 
system (Microflex LT/SH, Bruker Daltonics, Germany). For this, the bacteria were cultivated 
on MRS medium after which the identification was performed by direct colony method by 
following the manufacturer’s instructions.  
 
Table 3 Lactic acid bacteria strains and origins 
 
VTT culture  
collection strain 
 code  
Species Origin/Source Additional Info 
E-78076 Lactobacillus plantarum Beer  
E-78079  Lactobacillus plantarum Beer  
E-91468 Lactobacillus plantarum Soft drink  
E-94566 Lactobacillus plantarum Orange soft drink 
extract 
 
E-95618 Lactobacillus plantarum Sour dough seed  
E-96608 Lactobacillus plantarum Sour dough  
E-981065 Lactobacillus plantarum Unknown  
E-981138  Lactobacillus plantarum Brewery  
E-991158  Lactobacillus plantarum Brewery  
E-991159  Lactobacillus plantarum Brewery  
E-011800 Lactobacillus plantarum Brewery  
E-032411 Lactobacillus plantarum Beer  
E-062634 Lactobacillus plantarum Brewery  
E-093106 Lactobacillus plantarum Sour whole milk  
E-09683  Lactobacillus plantarum Silage DSM 2648 
E-103137 Lactobacillus plantarum Plant material  
E-133328 Lactobacillus plantarum Cheese  
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E-183579 Lactobacillus plantarum Human saliva  
E-71034 Lactobacillus plantarum Unknown DSM 20205 
E-093129T Lactobacillus plantarum 
subsp. argentoratensis 
Fermented cassava 
roots (fufu) 
DSM 16365 
E-79098T Lactobacillus plantarum 
subsp. plantarum  
Pickled cabbage DSM 20174 
 
E-78080* Lactobacillus rhamnosus Beer  
E-93444* Lactobacillus rhamnosus Unknown ATCC 11443 
E-96031T Lactobacillus rhamnosus Unknown DSM 20021 
E-96666 Lactobacillus rhamnosus Human faeces ATCC 53103 
E-97763 Lactobacillus rhamnosus Ethanol fermentation  
E-97800* Lactobacillus rhamnosus Human faeces  
E-97948* Lactobacillus rhamnosus Human biopsy sample  
E-97951* Lactobacillus rhamnosus Human biopsy sample  
E-97959* Lactobacillus rhamnosus Human biopsy sample  
E 97960* Lactobacillus rhamnosus  Human biopsy sample  
E 97962* Lactobacillus rhamnosus Human biopsy sample  
E-981000* Lactobacillus rhamnosus Human biopsy sample  
E-001125 Lactobacillus rhamnosus Unknown NCIMB 10463 
E-052739  Lactobacillus rhamnosus Infant faeces  
E-052740  Lactobacillus rhamnosus Infant faeces  
E-052741 Lactobacillus rhamnosus Infant faeces  
E-093103 Lactobacillus rhamnosus Human faeces  
E-183563* Lactobacillus rhamnosus  Human saliva  
E-183564* Lactobacillus rhamnosus  Human faeces  
E-183565* Lactobacillus rhamnosus  Human saliva  
E-183566* Lactobacillus rhamnosus  Human saliva  
E-183567* Lactobacillus rhamnosus  Human faeces  
E-183568* Lactobacillus rhamnosus  Human saliva  
E-183569* Lactobacillus rhamnosus  Human faeces  
E-183570* Lactobacillus rhamnosus  Human faeces  
E-183571* Lactobacillus rhamnosus  Human faeces  
E-183572* Lactobacillus rhamnosus  Human saliva  
E-183573* Lactobacillus rhamnosus  Human faeces  
E-183574* Lactobacillus rhamnosus  Human faeces  
E-183575* Lactobacillus rhamnosus  Human saliva  
E-183576* Lactobacillus rhamnosus  Human  
E-183577* Lactobacillus rhamnosus  Human  
E-183578 Lactobacillus rhamnosus Human saliva  
 
E-90389 Leuconostoc citreum Split kernel of barley  
E-90415 Leuconostoc citreum Split kernel of barley  
E-91451 Leuconostoc citreum Barley malt  
E-91452 Leuconostoc citreum Barley malt  
12 
 
 
 
E-93497 Leuconostoc citreum Malting process  
E-93504T Leuconostoc citreum Honey dew of rye ear DSM 5577 
E-981082 Leuconostoc citreum Processed oat  
E-093125 Leuconostoc citreum Sugar solutions and 
refineries 
DSM 20188 
E-143382 Leuconostoc citreum Barley  
E-153421 Leuconostoc gelidum Packaged broiler 
chicken cuts 
 
E-153484 Leuconostoc kimchii Spontaneous faba 
bean fermentation 
 
E-98974T Leuconostoc lactis Milk DSM 20202 
E-032298 Leuconostoc lactis Syrup sample  
E-011779 Leuconostoc mesenteroides Immobilized main 
beer fermentation 
 
E-093124 Leuconostoc mesenteroides Sugar refineries ATCC 11449 
E-91461T Leuconostoc mesenteroides 
subsp. mesenteroides 
Fermenting olives DSM 20343 
E-062512 Leuconostoc mesenteroides 
subsp. mesenteroides 
Root beer ATCC 10830A 
E-143337 Leuconostoc mesenteroides 
subsp. mesenteroides 
Organic carrot    
E-143338 Leuconostoc mesenteroides 
subsp. mesenteroides 
Organic carrot   
E-143339 Leuconostoc mesenteroides 
subsp. mesenteroides 
Organic carrot    
E-143340 Leuconostoc mesenteroides 
subsp. mesenteroides 
Organic carrot   
E-98970T Leuconostoc 
pseudomesenteroides 
Cane juice DSM 284 
E-981034 Leuconostoc 
pseudomesenteroides 
Aromatic mineral 
water 
 
E-001383 Leuconostoc sp. Beer  
E-143385 Leuconostoc sp. Oat  
E-143386 Leuconostoc sp. (citreum?) Oat  
E-143384 Leuconostoc sp. 
 (mesenteroides?) 
Oat  
E-143381 Leuconostoc sp. 
 (pseudomesenteroides) 
Barley   
E-143383 Leuconostoc sp. 
 (pseudomesenteroides) 
Barley   
 
E-072749 Weissella cibaria Fermented wheat bran  
E-153485 Weissella cibaria Faba bean 
fermentation 
 
E-163495 Weissella cibaria Celery  
E-163497 Weissella cibaria Faba bean flour  
E-082762T Weissella cibaria  Chili bo DSM 15878 
E-90392 Weissella confusa Soured carrot mash DSM 20194 
E-143403 Weissella confusa Protein-rich fraction 
of faba bean 
 
E-153454 Weissella confusa Plums   
E-153455 Weissella confusa Plums   
E-153457 Weissella confusa Brussel sprouts   
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E-153458 Weissella confusa Brussel sprouts   
E-153459 Weissella confusa Non peeled rye bran   
E-153460 Weissella confusa Non peeled rye bran   
E-153461 Weissella confusa Figs  
E-163496 Weissella confusa Raw milk  
E-90393T Weissella confusa  Sugar cane DSM 20196 
E-072748 Weissella sp. Fermented wheat bran   
E-072750 Weissella sp. Fermented wheat bran   
E-083076 Weissella sp. Fermented wheat bran  
E-153482 Weissella sp.  Faba bean 
fermentation 
 
E-072747  Weissella viridescens Wheat bran  
E-98966T Weissella viridescens  Cured meat products DSM 20410 
T= Type strain, *= The MIC values for  AM, CM, EM, GM, SM and TC were defined by Korhonen 
et al. (2010) . The values were used in the present study to obtain more comprehensive data sets. 
 
2.2 Determination of MIC values 
 
The MIC values of the eight antibiotics used in the EFSA’s assessment were defined by 
Etest® method according to guidelines of the manufacturer [37]. The antibiotics used in this 
study were ampicillin (AM), chloramphenicol (CL), clindamycin (CM), erythromycin (EM), 
gentamicin (GM), kanamycin (KM), streptomycin (SM) and tetracycline (TC) (bioMérieux, 
France). The concentration range of the selected antibiotics was 0.16-256 µg mL-1 except for 
streptomycin it was 0.064-1024 µg mL-1. 
 The colonies of selected strains were suspended in 5 mL of sterile 0.85 % (w/v) 
NaCl solution and the suspension corresponding to McFarland 1 was applied on LSM agar 
(90 % (v/v) Iso-sensitest broth, 10 % (v/v) MRS broth and 1.5 % (w/v) agar (Klare et al, 
2005)). The plates containing the antibiotic strips were incubated anaerobically or in 
microaerophilic conditions for 48 h at 25-37 °C depending on the strain. After 48 h 
incubation the MIC values were determined as the concentration value were no growth was 
observed according to guidelines of the manufacturer given for each antibiotic. 
 For certain L. rhamnosus strains of VTT’s culture collection the MIC values to  
AM, CM, EM, GM, SM and TC were already determined in the previous study [39]. These 
strains are shown in Table 3. The MIC values detected in Korhonen et al. (2010) study were 
used in the present study to obtain more comprehensive data set for Lactobacillus rhamnosus 
species.  
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 The proposed cut-off values for Weissella sp. strains were defined by visual and 
statistical analysis. The statistical cut-off values were determined by using ECOFFinder (v. 
2.0) program which estimates the cut-off values from the data set [40]. 
 
2.3 DNA extraction and detection of antibiotic resistance genes 
 
Genomic DNA from the studied strains were extracted by using a commercial DNA 
extraction kit (NucleoSpin® Microbial DNA, Macherey-Nagel, Germany) and the 
concentrations of isolated DNA were then estimated by using NanoDrop 2000 
spectrophotometer (Thermo Scientific, USA). Selected antibiotic resistance genes were 
detected by PCR (Polymerase Chain Reaction). Targeted AMR genes were selected based on 
the results of MIC determinations and phenotypic resistance patterns.  The chosen AMR 
genes expressed resistance to ampicillin (blaZ: LS483313.1, mecA: KC243783), 
chloramphenicol (cat: CP019573.1), clindamycin (lnuA: EU596446.1) and tetracycline (tetM: 
CP018888.1, tetK: NC_013452.1). These genes were selected based on the results of 
previous antibiotic susceptibility studies for lactic acid bacteria [41–43]. 16S rRNA gene 
amplification was performed to ensure the quality of the DNA extractions and the absence of 
PCR inhibitors. Positive controls for blaZ, mecA, lnuA and tetM genes were found by using 
CARD and MEGARes databases with Blastn 2.8.1+ search [44–46]. Two positive control 
strains (Staphylococcus aureus ssp. aureus, DSM 11822 and Staphylococcus simulans, DSM 
20322) had other resistance genes as well since cat or tetK genes were detected from these 
strains. The presence of cat and tetK genes in the strains was confirmed by sequencing of the 
amplicons. Raw sequences were quality checked and consensus was built by using Geneious 
(version 6.1.8) software. The obtained sequences were compared to those included in to 
CARD database by using BLAST search. 
The specific primers for AMR genes, product sizes, primer references, PCR 
programs, annealing temperatures and positive controls are shown in Table 4. PCR reactions 
was performed in 15 µl volumes containing 5.4 µl sterile H2O, 7.5 µl 2x MyTaqTM Red Mix 
(BIO-25043, Bioline, UK), 0.2 µM of each gene specific primers (Sigma-Aldrich, USA) and 
1.5 µl of DNA template. PCR amplifications were done by using Mastercycler® Gradient 
thermal cycler (Eppendorf, Germany). PCR products were stained with Midori Green 
Advance (MG 04, Nippon Genetics, Japan) and analyzed by gel electrophoresis (120 V, 2 h) 
on 1 % agarose gel in 0.5 x TBE buffer (161-0770, Bio-rad, Germany). 1 Kb DNA Ladder 
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(15615-016, Invitrogen) and GeneRuler 100 bp Plus DNA Ladder (SM0321, Thermo 
Scientific) were used for the evaluation of the fragment sizes of the PCR products.  
 
  
 
Table 4 Gene-specific primers, primer references, product sizes, annealing temperatures, used PCR programs and used positive controls for PCR 
detection 
 
Antibiotic Gene Primer sequence (5’-3’) Product 
size (bp) 
Primer 
reference 
Annealing 
temperature 
(°C) 
PCR program Positive 
control strains 
Ampicillin blaZ f-CAGTTCACATGCCAAAGAG 
r-TACACTCTTGGCGGTTTC 
846 [47] 54 95 °C: 3 min, 95 °C: 30s, 54 
°C: 30s, 72 °C: 1 min, 72 °C: 
10 min, 30 cycles 
Staphylococcus 
simulans, DSM 
20322 
 
 mecA f-GGGATCATAGCGTCATTATTC 
r-AGTTCTGCAGTACCAGATTTGC 
 
1429 [48] 58 95 °C: 3 min, 95 °C: 30s, 58 
°C: 30s, 72 °C: 30 s, 72 °C: 
10 min, 30 cycles 
Staphylococcus 
aureus ssp. 
aureus, DSM 
11822 
Tetracycline tetM f-GAACTCGAACAAGAGGAAAGC 
r-ATGGAAGCCCAGAAAGGAT 
740 [49] 60 95 °C: 3 min, 95 °C: 30s, 60 
°C: 30s, 72 °C: 1 min, 72 °C: 
10 min, 30 cycles 
Lactobacillus 
amylophilus,  
DSM 20533 
 tetK f-TTATGGTGGTTGTAGCTAGAAA 
r-AAAGGGTTAGAAACTCTTGAAA 
348 [50] 55 95 °C: 3 min, 95 °C: 30s, 55 
°C: 30s, 72 °C: 1 min, 72 °C: 
10 min, 30 cycles 
Staphylococcus 
simulans,  
DSM 20322 
Clindamycin lnuA (=linA) f-GGTGGCTGGGGGGTAGATGTATTAACTGG 
r-GCTTCTTTTGAAATACATGGTATTTTTCGATC 
323 [51] 57 94 °C: 3 min, 94 °C: 30s, 57 
°C: 30s, 72 °C: 30 s, 72 °C: 
10 min, 30 cycles 
Lactobacillus 
reuteri, ATCC 
55730 
Chloramphenicol cat f-TTAGGTTATTGGGATAAGTTA 
r-GCATGRTAACCATCACAWAC 
300 [52] 54 95 °C: 3 min, 95 °C: 30s, 54 
°C: 30s, 72 °C: 45 s, 72 °C: 
10 min, 30 cycles 
Staphylococcus 
aureus ssp. 
aureus, DSM 
11822 
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3 Results  
 
3.1 Identification of lactic acid bacterial strains 
 
Since the strains were selected from the culture collection and some strains had been 
identified to the species level more than 10 years ago by partial 16S rRNA gene sequencing, 
MALDI TOF based identification of the strains was performed. This was also done in order 
to check the purity of the strains.   
 In general, the species-level confirmation was detected in the genera 
Lactobacillus and Leuconostoc. For Weissella strains mainly genus-level identification were 
obtained due to the small number of reference strains in the MALDI Biotyper database.   
 
3.2 MIC determinations 
 
The MIC values were determined at the concentration value where no growth was observed. 
In Figure 1 the inhibition zones of Leuconostoc citreum E-93497 strain are displayed to 
illustrate the E-test method.  
 
 
 
Figure 1 Inhibition zones of Leuconostoc citreum E-93497 strain for A: ampicillin, 
chloramphenicol, clindamycin, erythromycin and B: gentamicin, kanamycin, streptomycin 
and tetracycline  
 
A B 
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MIC distributions of ampicillin, chloramphenicol, clindamycin, erythromycin, 
gentamicin, kanamycin, streptomycin and tetracycline for L. plantarum, L. plantarum, 
Leuconostoc sp. and Weissella sp. strains are displayed as histograms in Figures 2-9. The 
determined values are also summarized in Annex 1. The strain was considered as resistant if 
the determined MIC value was much higher than the cut-off value defined by EFSA. In 
addition, significantly different MIC values in the end of the concentration range are 
generally assumed to indicate acquired resistance. 
MIC distributions of ampicillin are shown in Figure 2. Generally, the 
distributions are following the normal distribution and no clearly resistant strains were 
detected. However, an additional peak at the MIC value of 2 µg mL-1 in the Leuconostoc sp. 
histogram was observed. The strains with MIC value of 2 µg mL-1 or higher represented L. 
mesenteroides. In addition, MIC value (2 µg mL-1) of one Weissella strain (Weissella cibaria 
E-153485) was slightly higher than the other determined MIC values.  
 
 
 
Figure 2. Ampicillin MIC distributions of Leuconostoc sp., Weissella sp., L. plantarum and L. 
rhamnosus strains. On the X-axis is the concentration of antibiotic (µg mL-1) and on the Y-
axis the number of strains.  
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MIC distributions of chloramphenicol seemed to conform to a normal 
distribution and no big variations in the MIC values were observed with the exception of one 
L. rhamnosus strain (E-001125) which exhibited clear resistance to chloramphenicol (Figure 
3). 
 
 
Figure 3. Chloramphenicol MIC distributions of Leuconostoc sp., Weissella sp., L. plantarum 
and L. rhamnosus strains. On the X-axis is the concentration of antibiotic (µg mL-1) and on 
the Y-axis the number of strains. 
 
Clindamycin MIC distributions are displayed in Figure 4. Generally, 
Leuconostoc sp. and Lactobacillus rhamnosus strains were susceptible to clindamycin and the 
determined MIC values followed a normal distribution. However, six Leuconostoc strains 
(Leuconostoc lactis E-032298, Leuconostoc citreum E-91451, Leuconostoc sp. 
(pseudomesenteroides) E-143383, Leuconostoc pseudomesenteroides E-98970T, 
Leuconostoc sp. (pseudomesenteroides) E-143381, Leuconostoc sp. E-143385) had higher 
MIC values (16, 32, and ≥256 µg mL-1). In addition, one L. rhamnosus strain (E-001125) 
showed clear resistance to clindamycin with the MIC value of ≥256 µg ml-1. 
Clindamycin MIC distributions of Weissella sp. and L. plantarum strains were 
more challenging to analyze due to the larger variation in the MIC values. As a result, the 
obtained MIC distributions were not following the normal distribution very well. In the case 
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of L. plantarum, six strains were more susceptible to clindamycin (0.023-0.047 µg mL-1) and 
two strains (L. plantarum E-96608, L. plantarum E-981065) were more resistant with MIC 
value of 24 µg mL-1. A similar phenomenon was detected in the MIC distribution of 
Weissella sp. strains as the MIC values varied between 0.032 and 4 µg mL-1.  
 
 
 
Figure 4. Clindamycin MIC distributions of Leuconostoc sp., Weissella sp., L. plantarum and 
L. rhamnosus strains. On the X-axis is the concentration of antibiotic (µg mL-1) and on the Y-
axis the number of strains. 
 
Concerning erythromycin, the distributions of Leuconostoc sp., Weissella sp. 
and L. plantarum strains appeared to conform the normal distribution and no significant 
resistances could be observed (Figure 5). A bimodal distribution, although separated by a 
single dilution, was detected in the distribution of L. rhamnosus strains.  
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Figure 5. Erythromycin MIC distributions of Leuconostoc sp., Weissella sp., L. plantarum 
and L. rhamnosus strains. On the X-axis is the concentration of antibiotic (µg mL-1) and on 
the Y-axis the number of strains. 
 
Gentamicin MIC distributions are displayed in Figure 6. Generally, the 
distributions appeared to follow a normal distribution. Eight Leuconostoc sp. strains, which 
were representing several species, formed an additional high peak (MIC value of 8 µg mL-1) 
at the end of the distribution. In addition, one Weissella sp. strain (W. cibaria E-163495) had 
slightly higher MIC value (MIC value of 16 µg mL-1) than the other strains. 
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Figure 6. Gentamicin MIC distributions of Leuconostoc sp., Weissella sp., L. plantarum and 
L. rhamnosus strains. On the X-axis is the concentration of antibiotic (µg mL-1) and on the Y-
axis the number of strains. 
 
Most of the determined strains exhibited resistance to kanamycin to a certain 
extent (Figure 7). MIC distributions of Leuconostoc sp. and Weissella sp. strains conformed 
to a normal distribution, although several strains (12 Leuconostoc sp. and four Weissella sp. 
strains) showed clear resistance to kanamycin (MIC ≥ 256 µg mL-1). In addition, four 
Weissella strains (two W. cibaria: E-082762T, E-153485 and two W. confusa: E-153459, E-
153460) with a MIC value of 64 µg mL-1 formed an additional high peak at the end of the 
distribution. In contrast, only four L. plantarum strains were somewhat sensitive to 
kanamycin while the rest of the strains showed clear resistance to kanamycin. Similar results 
were also obtained with L. rhamnosus strains as the MIC values of 64 % (21/33) strains were 
above 96 µg mL-1. 
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Figure 7 Kanamycin MIC distributions of Leuconostoc sp., Weissella sp., L. plantarum and L. 
rhamnosus strains. On the X-axis is the concentration of antibiotic (µg mL-1) and on the Y-
axis the number of strains. 
 
Generally, streptomycin MIC distributions followed a normal distribution with 
an exception of L. rhamnosus strains, where a bimodal distribution was observed (Figure 8). 
L. plantarum strains were uniformly susceptible to streptomycin. In contrast, one 
Leuconostoc sp. strain (L. pseudomesenteroides E-98970T) exhibited notable resistance with 
an unusually high MIC value (512 µg mL-1). The MIC distribution of Weissella sp. strains 
was more challenging to analyze since the determined MIC values were quite evenly 
distributed within different concentration levels. As a result, the distribution was not 
following a normal distribution pattern. Moreover, four Weissella sp. strains (were Weissella 
cibaria E-082762T, Weissella confusa E-143403, Weissella cibaria E-153485, Weissella 
cibaria E-163495) were more resistant to streptomycin than the others with MIC values of 
256 and 384 µg mL-1. 
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Figure 8. Streptomycin MIC distributions of Leuconostoc sp., Weissella sp., L. plantarum and 
L. rhamnosus strains. On the X-axis is the concentration of antibiotic (µg mL-1) and on the Y-
axis the number of strains. 
 
Tetracycline MIC distributions of Leuconostoc, Weissella sp., L. plantarum and 
L. rhamnosus strains were generally following a normal distribution (Figure 9). No clear 
deviation were detected in the distribution of Leuconostoc sp. and L. rhamnosus strains. By 
contrast, two Weissella sp. strains (Weissella confusa E-153461, Weissella viridescens E-
98966T ) exhibited slightly higher resistance to tetracycline with MIC values of 12 and 16 µg 
mL-1. Furthermore, one L. plantarum strain (E-183579) was clearly resistant (MIC ≥ 256 µg 
mL-1).  
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Figure 9. Tetracycline MIC distributions of Leuconostoc sp., Weissella sp., L. plantarum and 
L. rhamnosus strains. On the X-axis is the concentration of antibiotic (µg mL-1) and on the Y-
axis the number of strains. 
 
The determined MIC values exceeded the cut-off values defined by EFSA for 
certain antibiotics (Table 5).  The main overruns were detected in the case of 
chloramphenicol and kanamycin. 85 % (28/33) of L. rhamnosus and 79 % (23/29) of 
Leuconostoc sp. strains had higher MIC values than the EFSA’s cut-off value for 
chloramphenicol (4 µg mL-1). A similar phenomenon was observed in the case of kanamycin 
as 86 % (18/21) L. plantarum, 73 % (24/33) L. rhamnosus and 97 % (28/29) Leuconostoc sp. 
strains had higher MIC value than the defined cut-off value (64 and 16 µg mL-1, 
respectively). In addition, 52 % (11/21) of the MIC values for erythromycin in L. plantarum 
strains and 48 % (14/29) streptomycin MIC values of Leuconostoc sp. strains were detected 
to have higher MIC values than the defined cut-off values (1 and 64 µg mL-1, respectively) 
The proposed cut-off values for Weissella sp. were compared to the results 
obtained in statistical analysis (Table 6). The results of visual analysis were corresponding 
well with the results obtained in statistical analysis with a few exceptions (Table 6).  The 
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statistical analysis defined higher cut-off values for chloramphenicol, clindamycin and 
streptomycin distributions than obtained in visual analysis.  
 
Table 5. Number of the strains with higher MIC value than the cut-off value (µg mL-1) 
defined by EFSA 
 
Antibiotic L. plantarum 
EFSA’s 
cut-off 
L. rhamnosus 
EFSA’s 
cut-off 
Leuconostoc sp. 
EFSA’s 
cut-off 
Ampicillin 0 % (0/21) 2 0 % (0/33) 4 7 % (2/29) 2 
Chloramphenicol 19 % (4/21) 8 85 % (28/33) 4 79 % (23/29) 4 
Clindamycin 29 % (6/21) 4 3 % (1/33) 4 21 % (6/29) 1 
Erythromycin 52 % (11/21) 1 0 % (0/33) 1 14 % (6/29) 1 
Gentamicin 0 % (0/21) 16 0 % (0/33) 16 0 % (0/29) 16 
Kanamycin 86 % (18/21) 64 73 % (24/33) 64 97 % (28/29) 16 
Streptomycin - - 0 % (0/33) 32 48 % (14/29) 64 
Tetracycline 10 % (2/21) 32 0 % (0/33) 8 0 % (0/29) 8 
 
Table 6. Defined cut-off values for Weissella sp. strains by visual and statistical analysis (µg 
mL-1) 
Method 
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Visual 
analysis 
2 12 4 4 16 128 128 8 
Statistical 
analysis 
2 16 8 4 16 128 256 8 
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3.3 PCR detection of AMR genes 
 
The positive controls for selected AMR genes were used to ensure the validity of PCR 
reactions. The presence of the genes in the positive controls were verified by PCR (Figure 
10).  
Additionally, to check the quality of isolated DNA a PCR with primers specific 
for 16S rRNA gene was performed (data not shown). Positive controls and 16S rRNA 
reactions gave strong amplicons indicating that there were no technical problems in the PCR. 
 
 
 
Figure 10 Amplicons of the positive controls. 1: tetK (348 bp) 2: tetM (740 bp) 3: blaZ (846 
bp) 4: mecA (1429 bp) 5: lnuA (323 bp) 6: cat (300 bp) Molecular marker: GeneRuler 100 bp 
Plus DNA Ladder 
 
Ampicillin, chloramphenicol, clindamycin and tetracycline resistance genes 
blaZ, mecA, cat, lnuA, tetM and tetK were not detected by PCR in any of the strains even 
though several strains were found to exhibit resistance in the phenotypic testing.  
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4 Discussion 
 
Lactic acid bacteria play an essential role in the food industry as starters and probiotics [9]. 
As the antimicrobial resistance is getting more widespread and the risk of spreading AMR 
genes is increasing, it is important to consider beneficial bacteria as a potential pool of 
transmissible AMR genes. Especially as fermented foods contain large numbers of live 
bacteria and are thus favorable habitats for gene transfer [14]. 
Antibiotic susceptibility of lactic acid bacteria has been studied by using several 
methods including broth microdilution, disk diffusion and E-test method. E-test method was 
selected for the present study due to its simple technological requirements and suitability for 
screening multiple strains with several antibiotics at the same time. However, E-test method 
has also some inherent challenges. If pinpoint colonies and hazes inside the inhibition zones 
in addition to double zones of inhibition are detected the defining of exact MIC values can be 
challenging. These phenomena were detected with clindamycin, gentamicin, streptomycin 
and kanamycin. These observations may be explained by spontaneous mutations and 
decreased antibacterial activity during incubation period [53, 54]. Moreover, the E-test 
method is based on a visual evaluation of the MIC values and therefore the results may 
depend on the person performing the analysis. Therefore, E-test is best suited for screening of 
clear antimicrobial resistances in a bacterial population and not for defining exact MIC 
values.  
 Previous studies have reported that L. rhamnosus, L. plantarum, Leuconostoc 
sp. and Weissella sp. strains are generally sensitive to ampicillin as the determined MIC 
values have typically remained under 2 µg mL-1 [8, 14, 55–58]. The same results were 
observed in the present study since majority of the determined MIC values (except two MIC 
values of Leuconostoc sp. strains) remained under EFSA’s cut-off values. In addition, the 
genes expressing ampicillin resistance, blaZ and mecA, were not detected in any of the 
studied strains. Moreover, the additional high peak at the end of the distribution of 
Leuconostoc sp. strains seemed to be species specific, which might indicate that the 
susceptibility determinations should be performed in species-level instead of genus also for 
Leuconostocs.   
Chloramphenicol MIC values for L. rhamnosus and Leuconostoc sp. strains 
were generally somewhat above the cut-off value (4 µg mL-1) defined by EFSA. In addition, 
one L. rhamnosus strain exhibited clear resistance to chloramphenicol. However, cat gene 
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were not observed in any of the strains. Several studies have obtained similar results and the 
detected MIC values have mainly been above 4 µg mL-1 [8, 56, 59]. On the other hand, few 
studies have also determined MIC values under 4 µg mL-1 correlating well with the defined 
cut-off values [14, 43, 55, 57, 60]. Chloramphenicol MIC values of L. plantarum strains have 
generally reported to be under 4 µg mL-1 [43, 55, 58]. The results obtained in this study were 
slightly higher although only four L. plantarum strains had a MIC value above the EFSA’s 
cut-off value (8 µg mL-1). As for Weissella sp. strains, the suggested cut-off value of 
chloramphenicol is 12 µg mL-1 in the visual analysis and 16 µg mL-1 in statistical analysis. 
The results of previous studies are correlating well with the observations of this study since 
the chloramphenicol MIC values of Weissella sp. strains are reported not to exceed 16 µg 
mL-1  [43, 56, 61].  
 Generally, Leuconostoc sp. and L. rhamnosus strains were susceptible to 
clindamycin having MIC values below the EFSA’s cut-off value (1 and 4 µg mL-1, 
respectively). Similar results have also been reported in earlier studies [8, 57]. However, 
several strains exhibited clear resistance to clindamycin as significantly higher MIC values 
than the defined cut-off values were detected. Interestingly, L. rhamnosus strain (E-001125), 
which showed clear resistance to chloramphenicol, was also resistant to clindamycin. These 
observations might indicate acquired resistance even though the detected clindamycin 
resistance gene, lnuA, was not detected in this or any other of the examined strains. 
Previously, chloramphenicol and clindamycin have been reported to have partly overlapping 
inhibition sites, which could explain the cross-resistance for these antibiotics [62]. About one 
third of L. plantarum strains had clindamycin MIC value above the defined cut-off value (4 
µg mL-1). However, a wide clindamycin MIC range was detected in L. plantarum and 
Weissella sp. strains. Similar phenomenon was observed in previous antibiotic susceptibility 
studies of L. plantarum [6, 57, 63, 64]. Earlier studies of clindamycin susceptibilities in 
Weissella species are limited and the reported MIC values have varied between 0.064 and 0.5 
µg mL-1 [65, 66]. There is no obvious explanation for the wide MIC ranges but one theory is 
that the phenomenon could be caused by mutations [67]. The mode of action of clindamycin 
is based on the inhibition of protein synthesis in the 50S ribosomal subunit by affecting the 
peptidyl transferase reactions [68]. It has been suggested that clindamycin’s ability to inhibit 
protein synthesis might decrease if the synthesized peptide has already reached the critical 
length [68]. This observation might also explain the wide range of determined MIC values.  
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Several Leuconostoc sp. and L. plantarum strains had MIC values above the 
defined cut-off value (1 µg mL-1) for erythromycin. Cross-resistance between clindamycin 
and erythromycin, also known as MLSB (macrolide-lincosamide-streptogramin B) resistance, 
is considered to be to the overlapping inhibition sites of these antibiotics [6, 69]. However, 
the strains with high clindamycin MIC values in the present study did not have high 
erythromycin MIC values and therefore no cross-resistance was observed. Generally, MIC 
values below 1 µg mL-1 for erythromycin have been detected for Weissella sp. strains  
although more resistance strains have also been observed (MIC 16 µg mL-1) [43, 56, 65]. 
However, since MIC distributions in Weissella have been reported only to a limited extent 
and therefore it is difficult to compare the results. All the detected L. rhamnosus strains were 
susceptible to erythromycin even though a bimodal distribution was observed for the MIC 
values. Similar phenomenon was detected in the streptomycin MIC distribution of L. 
rhamnosus strains. Several studies have reported the occurrences of bimodal distributions in 
the context of streptomycin and erythromycin [14, 70, 71]. In closer analysis, Korhonen et al. 
(2010) detected systematically somewhat lower MIC values for L. rhamnosus strains with 
both antibiotics, which can be observed as bimodal distribution. Interestingly, this 
phenomenon was not observed in the MIC distributions of other tested antibiotics. These 
differences might be explained by different growth conditions and techniques applied in the 
MIC determination.  
 About half of the studied Leuconostoc sp. strains had higher MIC value for 
streptomycin than the defined cut-off value (64 µg mL-1). A wide variety of streptomycin 
MIC values (2-2048 µg mL-1) has been reported for Leuconostoc strains in previous studies 
[8, 14, 56]. One potential explanation for the wide streptomycin MIC range  may be the 
common occurrence of pinpoint colonies at the inhibition zone during the susceptibility 
testing which  hampers the correct identification of the MIC values [39, 54]. High 
streptomycin MIC values were also detected in L. plantarum and Weissella sp. strains. 
Similar results were obtained in previous studies as well [6, 56, 57, 65].  
Relatively high MIC values for aminoglycosides including streptomycin, 
gentamicin and kanamycin is typical among many lactic acid bacteria and is probably 
associated to the lack of cytochrome-mediated electron transport that affects uptake of the 
drug [52]. This correlates well also with the kanamycin MIC distributions as 86 % L. 
plantarum, 73 % L. rhamnosus and 97 % Leuconostoc sp. strains had higher MIC value than 
the defined cut-off values (64, 64, and 16 µg mL-1, respectively). On the other hand, 
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susceptible strains were also detected.  Re-evaluation of the cut-off values is thus warranted 
and can be done when more data on the MIC distribution has accumulated. 
Interestingly, all the examined strains were susceptible to gentamicin even 
though they exhibited resistance to streptomycin and kanamycin. Similar results have been 
observed in previous studies [57, 71, 72]. Susceptibility to gentamicin might be explained by 
its ability to pass through the membrane more effectively than other aminoglycosides due to 
the differences in structures and interactions with the membrane [73]. 
Generally, all the examined L. rhamnosus, L. plantarum, Leuconostoc sp. and 
Weissella sp. strains were susceptible to tetracycline with an exception of two L. plantarum 
strains which had MIC values above the defined cut-off value (32 µg mL-1). However, none 
of the studied strains carried the detected tetracycline resistance genes (tetK and tetM). 
Similar tetracycline MIC ranges have also been reported in several studies [6, 39, 56, 57, 64, 
66].  
The problem with many beneficial bacteria is that there is much less 
information about MIC values than for pathogenic bacteria. Improving the current cut-off 
values can only happen with the accumulation of new MIC distribution data for these 
species/genera.  Differences in the MIC values detected in different studies are probably 
partially explained by the different sources of the studied strains and variations in the 
methods used. Generally, no major disagreements in the results of various antibiotic 
susceptibility test methods, such as E-test, disk diffusion and microdilution, have been 
observed. The most notable differences between agar-based methods and broth micro dilution 
methods are reported with clindamycin, erythromycin and tetracycline [39, 54]. These 
observations are explained by the changes in the action of antimicrobial agents in different 
mediums and by the observations of pinpoint colonies and double zones of inhibition in agar-
based methods [39, 54]. 
So far, EFSA has not defined any cut-off values for Weissella species because 
no sufficient evidence of their safe consumption has been reported and therefore QPS status 
for Weissella sp. strains has not been granted [74]. The cut-off values of genus Leuconostoc 
were compared to the proposed cut-off values of Weissella strains since these two genera are 
phylogenetically close. Generally, the MIC values of both genera were correlating well and 
only small differences were detected. The cut-off values were the same for ampicillin, 
gentamicin and tetracycline. The proposed cut-off values of clindamycin and erythromycin 
were slightly higher in Weissella sp. than in Leuconostoc sp.. The differences of clindamycin 
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cut-off values might be explained with the wider MIC distribution of Weissella sp. strains. 
For chloramphenicol, kanamycin and streptomycin, the proposed cut-off values were 
significantly higher in Weissella sp. than in Leuconostoc sp. (12/16, 128, 128/256 µg mL-1 
versus 4, 16, 64 µg mL-1, respectively). However, for these antibiotics, most of the 
determined Leuconostoc sp. strains had higher MIC values than the defined cut-off values as 
well indicating that EFSA’s cut-off values may require re-evaluation. These results 
demonstrate that Weissella sp. strains do not cause greater safety risk than Leuconostoc 
species while considering their antibiotic resistance.  However, further antibiotic 
susceptibility studies are needed for defining better cut-off values since only small number of 
Weissella strains were examined in present study. 
Interestingly, none of the screened antibiotic resistance genes (blaZ, mecA, cat, 
lnuA, tetM and tetK) was detected in the studied strains even though a clear phenotypic 
resistance was observed in several strains. Since no positive PCR signals were obtained in 
any of the strains it is obvious that none of the strains had inactive AMR genes which would 
lead into phenotypical susceptibility [52, 75]. These results might be explained by the small 
number of the studied genes, as based on MEGARes database, multiple genes encode 
resistance to ampicillin, chloramphenicol, clindamycin and tetracycline. The genes studied in 
present study were selected based on the observations of previous studies which indicate that 
these genes, particularly resistance genes to chloramphenicol and tetracycline, can be found 
among lactic acid bacteria [41–43, 71]. Different methods have been used for the detection of 
AMR genes including PCR and DNA microarray methods in addition to whole genome 
sequencing [14, 64, 71].  For further studies, DNA microarray method might be more suitable 
method for screening of the resistance genes since multiple genes can be detected at the same 
time [64]. After the screening, the positive results can be ensured with more specific methods 
[64]. Whole genome sequencing (WGS) is a suitable option if not too many strains have to be 
studied.  WGS enables the identification of new potential AMR resistance mechanisms and 
genetic elements [76].  In addition to DNA, RNA can be used as a starting material for 
sequence analysis enabling the detection of expressed genes [76]. However, this method is 
too laborious and complex to be used for the studies on several strains. 
The results obtained in the present study provided more information about the antibiotic 
susceptibility profiles and the safety of L. plantarum, L. rhamnosus, Leuconostoc sp. and 
Weissella sp. strains. In addition, new, tentative cut-off values for Weissella sp. strains were 
proposed. In the future, even more strains of different origins should be studied to produce 
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robust MIC distributions, preferably in species-specific manner. Antibiotic susceptibility 
determinations for lactic acid bacteria should be performed using standardized methods as the 
incubation conditions might have an effect on the obtained results. With standardized 
methods, more reliable comparison of the results of various studies can be performed. 
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Annex 1 MIC distributions of ampicillin, chloramphenicol, clindamycin, erythromycin, gentamicin, kanamycin, tetracycline and streptomycin for 
Lactobacillus plantarum, Lactobacillus rhamnosus, Leuconostoc sp. and Weissella sp. strains.  
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Ampicillin Leuconostoc 
sp. 
29 
         
1 9 5 6 2 4 2 
     
        
 Weissella sp.  22      1 1 1 2 4 8 4   1               
 L. plantarum 21       3 4 5 4 2 2 1                 
 L. rhamnosus 
 
33           2 6 14 7 4               
Chloramphen
icol 
Leuconostoc 
sp. 
29               1 2 3 9 9 5          
 Weissella sp.  22                 4 9 8 1          
 L. plantarum 21                 3 7 7 3 1         
 L. rhamnosus 
 
33               1 1 3 9 9 7 2        1 
Clindamycin Leuconostoc 
sp. 
29 1   2 2 3 7 4 2 1 1          2 
 
2      2 
 Weissella sp.  22   1 
 
3 1 1   7 1 3 1 1 1 1 1             
 L. plantarum 21 
 
3 2 1     2 
 
1 1 1 1 1 1 1 2 2   2        
 L. rhamnosus 
 
33      1 4 6 3 6 6 4 2                1 
Erythromycin Leuconostoc 
sp. 
29         1 2 5 9 8 3 1               
 Weissella sp.  22            3 6 8 3 1 1            
 
 L. plantarum 21          1 
 
2 7 6 2 1 1 
 
1           
 L. rhamnosus 
 
33 
 
1 2 4 7 6 4 1 
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Gentamicin Leuconostoc 
sp. 
29             1 2 6 6 3 2 8 1          
 Weissella sp.  22               7 8 
 
5 1 
 
1         
 L. plantarum 21               4 5 3 4 3 2          
 L. rhamnosus 
 
33             2 7 12 8 3 1            
Kanamycin Leuconostoc 
sp. 
29                     1 1 1 3 6 4 
 
1 12 
 Weissella sp.  22                    1 
 
5 3 2 4 2 1 
 
4 
 L. plantarum 21                       1 1 1 2   16 
 L. rhamnosus 
 
33                      2 1 2 4 3 7 7 7 
Tetracycline Leuconostoc 
sp. 
29           1 1 3 11 12 1              
 Weissella sp.  22              1 6 6 6 1 
 
1 1         
 L. plantarum 21                  1 1 6 7 2 2 
 
1    1 
 L. rhamnosus 
 
33          3 13 8 8 1                
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Streptomycin Leuconostoc 
sp. 
29                 1  2 2 10 6 5 1 1  1   
 Weissella sp.  22                   4 5 4 2 3  3 1    
 L. plantarum 21                  1 1 2 2 10 4 1      
 L. rhamnosus 
 
33           5 14 4 2  1 4 2 1           
 
